Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Bureau of Competition published four reports on pharmaceutical patent settlement agreements filed under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) for fiscal ...

Ammar Mas-Oo-Di / EyeEm / Getty Images Many investors use free cash flow (FCF) to identify a company's ability to repay creditors or pay dividends and interest to shareholders. This aspect of a ...

Many healthcare companies are also highly dependent on Medicare reimbursement levels. Recent changes to Medicare allow the program to negotiate prices for some high-cost drugs with pharmaceutical ...

Yet, the cost of those innovations places new drugs out of reach for many patients and significantly burdens others. Are pharmaceutical companies earning too much? Deciding whether pharmaceutical ...

There are a lot of them and they're just quite competitive.” Li’s experience is illustrative of a trend that could pressure biotech companies in the U.S. and alter their drug development strategies.

His laboratory at the University of Washington announced on Wednesday that its disruptive artificial intelligence programs, for which Baker won the Nobel Prize, have succeeded for the first time in ...

Photo: Getty Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is introduced. Pfizer, Intel and other major employers are ...

SAN FRANCISCO, Jan 16 (Reuters) - The pharmaceutical industry ... is inevitably very highly politicized," he said. Biopharma companies would also like to see changes to the Inflation Reduction ...

AstraZeneca CFO Aradhana Sarin promised Phase III readouts and revenue growth in 2025 despite ongoing investigations of its Chinese operations. Credit: Bloomberg/ Getty Images AstraZeneca says a ...

2 M&A plays a key role in bringing highly lucrative medications to market, as large pharmaceutical companies often look to invest in young biotechnology companies for their innovative products.